{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T18:21:03Z","timestamp":1758824463473},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:p>Primary mediastinal large B-cell lymphoma (PMBL) is a mature large B-cell lymphoma of putative thymic B-cell origin involving the mediastinum with younger age distribution and better prognosis than diffuse large B-cell lymphoma (DLBCL), not otherwise specified. Recently, based on gene expression profile analysis and morphologic findings, cases of PMBL without mediastinal involvement have been reported. In this study, we analyzed 3 cases of nodal DLBCL with morphologic features of PMBL presenting in submandibular or supraclavicular lymph nodes, in middle-aged to elderly patients, 2 of them without clinical or radiologic evidence of mediastinal involvement. The 3 patients presented with stage I\/II disease and had excellent response to R-CHOP\/R-EPOCH therapy. The 3 cases showed MAL expression and were positive for CD23 and\/or CD30. All 3 cases expressed cyclin D1 with copy number gains of <jats:italic toggle=\"yes\">CCND1<\/jats:italic> gene but without rearrangement. There was no rearrangement of <jats:italic toggle=\"yes\">CIITA<\/jats:italic> or <jats:italic toggle=\"yes\">PDL1\/PDL2<\/jats:italic>. Reverse transcriptase-multiplex ligation-dependent probe amplification, a mRNA-based gene expression profile analysis revealed high probability of PMBL (87.6%, 98.7%, and 99%) in these 3 cases. Targeted next-generation sequencing analysis showed <jats:italic toggle=\"yes\">SOCS1<\/jats:italic> mutations in the 3 cases, and <jats:italic toggle=\"yes\">TNFAIP3<\/jats:italic> and <jats:italic toggle=\"yes\">XPO1<\/jats:italic> mutations in one, further supporting the diagnosis of PMBL. In conclusion, we report 3 cases of nodal PMBL, 2 of them without mediastinal mass, and expression of cyclin D1 due to copy number gains of <jats:italic toggle=\"yes\">CCND1<\/jats:italic> gene, a diagnostic pitfall with mantle cell lymphoma and DLBCL, not otherwise specified.<\/jats:p>","DOI":"10.1097\/pas.0000000000001154","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T22:31:33Z","timestamp":1538001093000},"page":"110-120","source":"Crossref","is-referenced-by-count":12,"title":["Cyclin D1-positive Mediastinal Large B-Cell Lymphoma With Copy Number Gains of CCND1 Gene"],"prefix":"10.1097","volume":"43","author":[{"given":"Bo-Jung","family":"Chen","sequence":"first","affiliation":[{"name":"Institute of Pathology and Neuropathology and Comprehensive Cancer Center T\u00fcbingen, University Hospital T\u00fcbingen, Eberhard-Karls-University, T\u00fcbingen, Germany"},{"name":"Department of Pathology, Shuang-Ho Hospital, Taipei Medical University, New Taipei City, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Ruminy","sequence":"additional","affiliation":[{"name":"INSERM U1245, UNIROUEN, University of Normandie"},{"name":"Department of Biological Hematology, Rouen University Hospital, Rouen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine G.","family":"Roth","sequence":"additional","affiliation":[{"name":"Division of Hematopathology, University of Pittsburgh School of Medicine, Pittsburgh, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Bisig","sequence":"additional","affiliation":[{"name":"Division of Hematopathology, University of Pittsburgh School of Medicine, Pittsburgh, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Mankel","sequence":"additional","affiliation":[{"name":"Institute of Pathology and Neuropathology and Comprehensive Cancer Center T\u00fcbingen, University Hospital T\u00fcbingen, Eberhard-Karls-University, T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Steinhilber","sequence":"additional","affiliation":[{"name":"Institute of Pathology and Neuropathology and Comprehensive Cancer Center T\u00fcbingen, University Hospital T\u00fcbingen, Eberhard-Karls-University, T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elodie","family":"Bohers","sequence":"additional","affiliation":[{"name":"INSERM U1245, UNIROUEN, University of Normandie"},{"name":"Department of Biological Hematology, Rouen University Hospital, Rouen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Jardin","sequence":"additional","affiliation":[{"name":"INSERM U1245, UNIROUEN, University of Normandie"},{"name":"Department of Biological Hematology, Rouen University Hospital, Rouen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falko","family":"Fend","sequence":"additional","affiliation":[{"name":"Institute of Pathology and Neuropathology and Comprehensive Cancer Center T\u00fcbingen, University Hospital T\u00fcbingen, Eberhard-Karls-University, T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven H.","family":"Swerdlow","sequence":"additional","affiliation":[{"name":"Division of Hematopathology, University of Pittsburgh School of Medicine, Pittsburgh, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Copie-Bergman","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Henri Mondor, APHP, Inserm U955, University of Paris-East, Creteil, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"de Leval","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leticia","family":"Quintanilla-Martinez","sequence":"additional","affiliation":[{"name":"Institute of Pathology and Neuropathology and Comprehensive Cancer Center T\u00fcbingen, University Hospital T\u00fcbingen, Eberhard-Karls-University, T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/annonc\/mdj030","article-title":"Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience","volume":"17","author":"Savage","year":"2006","journal-title":"Ann Oncol"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0002-9440(10)63815-1","article-title":"Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins","volume":"162","author":"Pileri","year":"2003","journal-title":"Am J Pathol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1309\/AJCP3Q1DHWKCQRWY","article-title":"Surface light chain expression in primary mediastinal large B-cell lymphomas by multiparameter flow cytometry","volume":"144","author":"Weinberg","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/00000478-200110000-00008","article-title":"Expression of bcl-6 and CD10 in primary mediastinal large B-cell lymphoma: evidence for derivation from germinal center B cells?","volume":"25","author":"de Leval","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/PAS.0000000000000771","article-title":"Performance of a commercially available MAL antibody in the diagnosis of primary mediastinal large B-cell lymphoma","volume":"41","author":"Gentry","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/modpathol.2012.129","article-title":"Utility of CD200 immunostaining in the diagnosis of primary mediastinal large B cell lymphoma: comparison with MAL, CD23, and other markers","volume":"25","author":"Dorfman","year":"2012","journal-title":"Mod Pathol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1097\/PAS.0000000000000297","article-title":"Expression of programmed cell death 1 ligand 2 (PD-L2) is a distinguishing feature of primary mediastinal (thymic) large B-cell lymphoma and associated with PDCD1LG2 copy gain","volume":"38","author":"Shi","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-13-0855","article-title":"PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies","volume":"19","author":"Chen","year":"2013","journal-title":"Clin Cancer Res"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1309\/AJCPKUG0UQO0HMDJ","article-title":"Clinicopathologic evaluation of MYC expression in primary mediastinal (thymic) large B-cell lymphoma","volume":"143","author":"Li","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1097\/PAS.0b013e31822bd476","article-title":"Aberrant expression of the dendritic cell marker TNFAIP2 by the malignant cells of Hodgkin lymphoma and primary mediastinal large B-cell lymphoma distinguishes these tumor types from morphologically and phenotypically similar lymphomas","volume":"35","author":"Kondratiev","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.pas.0000213334.40358.0e","article-title":"Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma","volume":"31","author":"Rodig","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.celrep.2015.10.008","article-title":"Genomic alterations in CIITA are frequent in primary mediastinal large B cell lymphoma and are associated with diminished MHC class II expression","volume":"13","author":"Mottok","year":"2015","journal-title":"Cell Rep"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1182\/blood-2011-05-326538","article-title":"The molecular pathogenesis of primary mediastinal large B-cell lymphoma","volume":"118","author":"Steidl","year":"2011","journal-title":"Blood"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1182\/blood-2013-10-535443","article-title":"Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma","volume":"123","author":"Twa","year":"2014","journal-title":"Blood"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1158\/1078-0432.CCR-15-2305","article-title":"Next-generation sequencing in diffuse large B-cell lymphoma highlights molecular divergence and therapeutic opportunities: a LYSA Study","volume":"22","author":"Dubois","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.2900","article-title":"Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma","volume":"46","author":"Gunawardana","year":"2014","journal-title":"Nat Genet"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/ajh.24451","article-title":"Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma","volume":"91","author":"Jardin","year":"2016","journal-title":"Am J Hematol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1097\/PAS.0000000000000473","article-title":"Identification of primary mediastinal large B-cell lymphoma at nonmediastinal sites by gene expression profiling","volume":"39","author":"Yuan","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1182\/bloodadvances.2017012534","article-title":"Checkpoint blockade in Hodgkin and non-Hodgkin lymphoma","volume":"1","author":"Merryman","year":"2017","journal-title":"Blood Adv"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1182\/blood.V94.10.3567.422k06_3567_3575","article-title":"The MAL gene is expressed in primary mediastinal large B-cell lymphoma","volume":"94","author":"Copie-Bergman","year":"1999","journal-title":"Blood"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1182\/blood-2015-10-673236","article-title":"Targetable genetic features of primary testicular and primary central nervous system lymphomas","volume":"127","author":"Chapuy","year":"2016","journal-title":"Blood"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","article-title":"MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers","volume":"471","author":"Steidl","year":"2011","journal-title":"Nature"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jmoldx.2015.01.007","article-title":"Accurate classification of germinal center B-cell-like\/activated B-cell-like diffuse large B-cell lymphoma using a simple and rapid reverse transcriptase-multiplex ligation-dependent probe amplification assay: a CALYM Study","volume":"17","author":"Mareschal","year":"2015","journal-title":"J Mol Diagn"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jmoldx.2017.07.007","article-title":"Determination of molecular subtypes of diffuse large B-cell lymphoma using a reverse transcriptase multiplex ligation-dependent probe amplification classifier: a CALYM Study","volume":"19","author":"Bobee","year":"2017","journal-title":"J Mol Diagn"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1182\/blood-2016-03-703819","article-title":"Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene","volume":"128","author":"Schmidt","year":"2016","journal-title":"Blood"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"16712","DOI":"10.18632\/oncotarget.3154","article-title":"Immunohistochemical and genomic profiles of diffuse large B-cell lymphomas: implications for targeted EZH2 inhibitor therapy?","volume":"6","author":"Dubois","year":"2015","journal-title":"Oncotarget"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1182\/blood-2003-11-3837","article-title":"Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels","volume":"104","author":"Specht","year":"2004","journal-title":"Blood"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1309\/42CQ0HU7XEY9QMQX","article-title":"A subset of CD5\u2212 diffuse large B-cell lymphomas expresses nuclear cyclin D1 with aberrations at the CCND1 locus","volume":"129","author":"Ehinger","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1365-2559.2008.03042.x","article-title":"Cyclin D1-positive diffuse large B-cell lymphoma","volume":"52","author":"Rodriguez-Justo","year":"2008","journal-title":"Histopathology"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.humpath.2012.03.021","article-title":"CD5(\u2212) diffuse large B-cell lymphoma with peculiar cyclin D1+ phenotype. Pathologic and molecular characterization of a single case","volume":"43","author":"Izquierdo","year":"2012","journal-title":"Hum Pathol"},{"key":"R35-20230922","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/cncr.28664","article-title":"Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program","volume":"120","author":"Ok","year":"2014","journal-title":"Cancer"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.anndiagpath.2016.10.003","article-title":"Cyclin D1 expression and polysomy in lymphocyte-predominant cells of nodular lymphocyte-predominant Hodgkin lymphoma","volume":"26","author":"Cho","year":"2017","journal-title":"Ann Diagn Pathol"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1182\/blood-2012-06-437210","article-title":"Primary mediastinal large B-cell lymphoma segregating in a family: exome sequencing identifies MLL as a candidate predisposition gene","volume":"121","author":"Saarinen","year":"2013","journal-title":"Blood"},{"key":"R38-20230922","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2559.2011.03745.x","article-title":"Primary pulmonary large B-cell lymphoma\u2014mediastinal type?","volume":"58","author":"Chen","year":"2011","journal-title":"Histopathology"},{"key":"R39-20230922","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1097\/PAS.0b013e31821ddaec","article-title":"A case of hairy cell leukemia with CCND1-IGH@ translocation: indolent non-nodal mantle cell lymphoma revisited","volume":"35","author":"Chen","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R40-20230922","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/ped.13027","article-title":"Bilateral ectopic cervical thymus presenting as a neck mass: ultrasound and magnetic resonance imaging","volume":"58","author":"Tanrivermis Sayit","year":"2016","journal-title":"Pediatr Int"},{"key":"R41-20230922","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00000478-198603000-00005","article-title":"Mediastinal diffuse large-cell lymphoma with sclerosis. A clinicopathologic study of 60 cases","volume":"10","author":"Perrone","year":"1986","journal-title":"Am J Surg Pathol"},{"key":"R42-20230922","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/01.MP.0000032534.81894.B3","article-title":"MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas","volume":"15","author":"Copie-Bergman","year":"2002","journal-title":"Mod Pathol"},{"key":"R43-20230922","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2559.2004.01969.x","article-title":"CD23 expression in mediastinal large B-cell lymphomas","volume":"45","author":"Calaminici","year":"2004","journal-title":"Histopathology"},{"key":"R44-20230922","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/ajcp\/112.2.241","article-title":"CD30 expression is common in mediastinal large B-cell lymphoma","volume":"112","author":"Higgins","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"R45-20230922","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1182\/blood-2012-10-461848","article-title":"CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study","volume":"121","author":"Hu","year":"2013","journal-title":"Blood"},{"key":"R46-20230922","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/bjh.13085","article-title":"CD30 expression in de novo diffuse large B-cell lymphoma: a population-based study from British Columbia","volume":"167","author":"Slack","year":"2014","journal-title":"Br J Haematol"},{"key":"R47-20230922","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/ejh.12680","article-title":"CD30 expression and its correlation with MYC rearrangement in de novo diffuse large B-cell lymphoma","volume":"97","author":"Wang","year":"2016","journal-title":"Eur J Haematol"},{"key":"R48-20230922","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1365-2141.1999.01678.x","article-title":"Molecular features of primary mediastinal B-cell lymphoma: involvement of p16INK4A, p53 and c-myc","volume":"107","author":"Scarpa","year":"1999","journal-title":"Br J Haematol"},{"key":"R49-20230922","first-page":"2017","article-title":"Molecular characterization of primary mediastinal B cell lymphoma","volume":"148","author":"Tsang","year":"1996","journal-title":"Am J Pathol"},{"key":"R50-20230922","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1016\/j.leukres.2012.07.011","article-title":"IGH@\/BCL6 rearrangement on the der(3)t(3;14)(q27;q32) in primary mediastinal large B-cell lymphoma","volume":"36","author":"Yamamoto","year":"2012","journal-title":"Leuk Res"},{"key":"R51-20230922","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1002\/cncr.27396","article-title":"Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab","volume":"118","author":"Akyurek","year":"2012","journal-title":"Cancer"},{"key":"R52-20230922","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1182\/blood-2004-09-3701","article-title":"Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line","volume":"105","author":"Melzner","year":"2005","journal-title":"Blood"},{"key":"R53-20230922","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1038\/sj.onc.1209151","article-title":"Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation","volume":"25","author":"Weniger","year":"2006","journal-title":"Oncogene"},{"key":"R54-20230922","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1182\/blood-2007-03-082511","article-title":"Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6","volume":"110","author":"Mottok","year":"2007","journal-title":"Blood"},{"key":"R55-20230922","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1182\/blood-2009-06-225839","article-title":"Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities","volume":"114","author":"Mottok","year":"2009","journal-title":"Blood"},{"key":"R56-20230922","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.20090528","article-title":"TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma","volume":"206","author":"Schmitz","year":"2009","journal-title":"J Exp Med"},{"key":"R57-20230922","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/PAI.0b013e318182d2aa","article-title":"CD5 negative, Cyclin D1-positive diffuse large B-cell lymphoma (DLBCL) presenting as ruptured spleen","volume":"17","author":"Teruya-Feldstein","year":"2009","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R58-20230922","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12308-010-0072-6","article-title":"Diffuse large B-cell lymphoma with both CD5 and cyclin D1 expression\u2014a case report and review of the literature","volume":"3","author":"Schneider","year":"2010","journal-title":"J Hematopathol"},{"key":"R59-20230922","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/modpathol.2009.173","article-title":"Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes","volume":"23","author":"Metcalf","year":"2010","journal-title":"Mod Pathol"},{"key":"R60-20230922","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/10428194.2010.540361","article-title":"Cyclin D1 positive diffuse large B-cell lymphoma is a post-germinal center-type lymphoma without alterations in the CCND1 gene locus","volume":"52","author":"Vela-Chavez","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"R61-20230922","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.humpath.2010.11.015","article-title":"CD5(\u2212) diffuse large B-cell lymphoma with peculiar cyclin D1+ phenotype. Pathologic and molecular characterization of a single case","volume":"42","author":"Lucioni","year":"2011","journal-title":"Hum Pathol"},{"key":"R62-20230922","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2559.2012.04260.x","article-title":"SOX11 is useful in differentiating cyclin D1-positive diffuse large B-cell lymphoma from mantle cell lymphoma","volume":"61","author":"Hsiao","year":"2012","journal-title":"Histopathology"},{"key":"R63-20230922","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/jclinpath-2017-204364","article-title":"Cyclin D1 overexpression in proliferation centres of small lymphocytic lymphoma\/chronic lymphocytic leukaemia","volume":"70","author":"Teixeira Mendes","year":"2017","journal-title":"J Clin Pathol"},{"key":"R64-20230922","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1309\/AJCPIVKZRMPF93ET","article-title":"Chronic lymphocytic leukemia\/small lymphocytic lymphoma with cyclin D1 positive proliferation centers do not have CCND1 translocations or gains and lack SOX11 expression","volume":"138","author":"Gradowski","year":"2012","journal-title":"Am J Clin Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201901000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:33:23Z","timestamp":1695422003000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201901000-00012"}},"subtitle":["A Study of 3 Cases With Nonmediastinal Disease"],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001154","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}